Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 17

Post COVID-19 Vertigo in a Patient with Hypothyroidism: A Case Report

Authors Calderon Guzman D, Osnaya Brizuela N, Valenzuela Peraza A, Ortiz Herrera M, Barragan Mejia G , Juarez Olguin H 

Received 28 January 2024

Accepted for publication 12 April 2024

Published 29 April 2024 Volume 2024:17 Pages 1845—1851

DOI https://doi.org/10.2147/DMSO.S459711

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Konstantinos Tziomalos



David Calderon Guzman,1 Norma Osnaya Brizuela,1 Armando Valenzuela Peraza,1 Maribel Ortiz Herrera,2 Gerardo Barragan Mejia,2 Hugo Juarez Olguin3

1Laboratory of Neurosciences. Instituto Nacional de Pediatria (INP), Mexico City, Mexico; 2Laboratory of Experimental Bacteriology. INP, Mexico City, Mexico; 3Laboratory of Pharmacology. INP, Mexico City, Mexico

Correspondence: Hugo Juarez Olguin, Laboratorio de Farmacología, Instituto Nacional de Pediatría. Avenida Imán, N 1, 3rd piso Colonia Cuicuilco CP 04530, Mexico City, Mexico, Tel/Fax +5255 10840900, Email [email protected]

Case Summary: Female nurse, 44-years-old with a weight of 127 pounds. She attended our emergency clinic for an urgent care due to post COVID-19 vertigo and anxiety. Her problem began with severe, short-lived attacks of objective-circular type vertigo, accompanied by nausea and vomiting. The symptoms occurred when she assumed a lying position, turn right and sat or stood upright.
Interventions: The patient received medical prescription for hypothyroidism, vertigo and anxiety symptoms. Oral route feeding was started and was well tolerated.
Outcomes: The patient showed good evolution with the treatment. Currently, she is at home with daily intake of levothyroxine and losartan without complications.
Conclusion: The clinical case suggests that in patients with hypothyroidism, COVID-19 infection may trigger and exacerbate vertigo and anxiety.

Keywords: hypothyroidism, COVID-19, vertigo, thyroid

Introduction

The coronavirus disease 2019 (COVID-19) pandemic is currently one of the major health concerns worldwide. The disease not only affects the physical health of the patients, but also their body physiological activities and mental wellbeing. Dizziness has been a very common and one of the significant clinical manifestations reported in routine clinical practice in the patients with COVID-19. Hypothyroidism is the result of inadequate production of thyroid hormone (TH) or inadequate action of TH in target tissues,1 and several studies have documented the increased prevalence of thyroid disorders in patients with diabetes or obesity,2 due hypothyroidism is closely associated with increased serum total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and triglyceride (TG), and multiple newly identified modulatory biomarkers, such as proprotein convertase subtilisin/kexin type 9 (PCSK9), angiopoietin-like protein (ANGPTLs), and fibroblast growth factors (FGFs), might play a role in modulating the risk of hyperlipidemia induced by this disorders.3 It is also important to recognize that exists congenital hypothyroidism (CH) is defined as TH deficiency at birth due to insufficient stimulation by the pituitary of the thyroid gland,4 and drugs that generate hypothyroidism by interaction in its treatment.5 The thyroid gland has the capacity and holds the machinery to handle the iodine efficiently when the availability of iodine becomes scarce, as well as when iodine is available in excessive quantities,6 in response to Thyroid Stimulating Hormone (TSH) release by the pituitary gland, a normally functioning thyroid gland will produce and secrete T4, which is then converted through deiodination (by type I or type II 5′-deiodinases) into its active metabolite T3. While T4 is the major product secreted by the thyroid gland, T3 exerts the majority of the physiological effects of the THs, and then, without sufficient quantities of circulating THs, symptoms of hypothyroidism begin to develop such as fatigue, increased heart rate, depression, dry skin and hair, muscle cramps, constipation, weight gain, memory impairment, and poor tolerance to cold temperatures. However; 150 microg iodine are daily required for TH synthesis, and the thyroid gland has intrinsic mechanisms that maintain normal thyroid function even in the presence of iodine excess.7

On the other hand, decompensated hypothyroidism is an endocrine emergency that commonly presents with altered mental status, as well as hypothermia, and depressed vital signs is a severe hypothyroid state, and is generally associated with multiple organ failure with the presence or absence of COVID-19, for this reason the clinicians should obtain a TSH and free thyroxine level when considering the diagnosis.8 It so as to not miss this critical diagnosis.

Case Presentation

Assessment completed and documented by medical service of Neurology, Endocrinology, Psychology and Otolaryngology.

This is a case of female nurse, 44-years-old with a weight of 127 pounds. She lives with her 2 sons and mom in her own house. She attended our emergency clinic for an urgent care due to post COVID-19 vertigo and anxiety.

Clinical History

She was diagnosed of hypothyroidism 19 years ago, managed with levothyroxine with complete compliance to the treatment. At 40, she began with hypertension, which is being managed with Losartan, also with strict compliance to treatment. For some years now, she has been on active yoga practice, which she usually performs 3 days per week and does a five-mile running exercises around her neighborhood 4 days per week. In all these years, she had been feeling completely stable when doing the exercises and carrying out her daily routines. After suffering from a two-time COVID-19 infection, she continued with her routine activities without sensing any complications of the infection. She began with her present problem with a fall after a sudden wake up from sleep. Since then, she began with dizziness, nausea and loss of balance at night as well as anxiety.

Core Tips

Patients with hypothyroidism who developed post-covid-19 symptoms of vertigo/dizziness and anxiety that receive treatment medicine and appropriate nutritional support may have reduced manifestation of these symptoms and may not have the need to visit the hospital, even when their symptoms remain persistent.

Medical History

  • - Hypothyroidism for 19 years.
  • - Hypertension since 40-years-old.
  • - Anosmia (loss of smell) for 2 months
  • - Ageusia (loss of taste) for 6 months
  • - Body pain for 2 weeks
  • - Lung inflammation for 2 weeks
  • - Weight loss 3%
  • - Vertigo
  • - Anxiety
  • COVID-19 Vaccination Information

  • - SINOVAC first dose
  • - SINOVAC Second dose
  • - ASTRAZENECA third dose
  • Hypothyroidism Managements

  • Levothyroxine 100µg, once daily.
  • Hypertension Managements

  • Losartan 50mg, twice daily
  • COVID-19 Managements

  • Beclometasone spray 100µg, twice daily
  • Paracetamol 500mg for pain, 4 times daily as the need may be.
  • Omeprazole 20mg, twice daily
  • Amoxicillin 500mg, twice daily
  • Vertigo Managements

  • Difenidol 25mg, 3 times daily
  • Betahistine 24mg for lose of balance, twice daily as the need may be.
  • Anxiety Managements

  • Citalopram 20mg, 1 time daily for 45 days
  • Diet

    Fish, chicken, eggs, olive oil, fruits, vegetables, Whole bread, juice of cactus (nopal) daily and cinnamon tea, lactose-free milk, sugar-free flavoring, corn, rice, beans. No-alcohol, No-smoking.

    Review of Systems

    Nocturia > 2 times every night

    Physical Exam

    Constitutional: Well-developed, well-nourished, irritable due to anxiety and vertigo

    Vitals: BP: Supine – 130/91, 107; Sitting – 138/78, 107; Standing – 146/95, 115. BMI 21.0.

    Head: Normocephalic / atraumatic.

    CV: Regular rhythm, tachycardic, without murmurs, rubs, or gallops.

    Respiratory: Clear to auscultation bilaterally.

    EA: Normal bowel tones, non-tender, non-distended.

    Musculoskeletal: UE Strength 5/5 throughout; LE strength 5/5 throughout and 5/5 at bilateral hip flexors. No knee joint laxity. Foot exam shows no calluses, ulcerations or deformities.

    Neurology: Cognitive screening: Normal.

    Tone/abnormal: No tremor, bradykinesia or rigidity. Sensation, proprioception and movements: DTRs normal.

    Identified Fall Risk Factors

    The results of the assessment tests indicate that her health is within normal limits.

    She is taking levothyroxine and losartan every day.

    Fall Prevention Plans

    1. She was recommended making dose adjustment or reduction of her medication for vertigo.
    2. She has to reassess her thyroid profile and avoid medications that cause falls.

    Complementary Studies

    Simple skull magnetic resonance of was normal.

    Adrenal gland tumor assay was normal.

    Relevance of This Case

    This case shows the importance of psychological support to the population after undergoing certain health images that would help them to implement quick coping strategies.

    Results

    There are several different test that can measure thyroid function and are blood test used to measure the health of thyroid.

    The results of thyroid blood tests (tables 1, 2, 3 and 4), were made in a Laboratory accredited by College of American Pathologists (CAP), and are described in a reference range of values. The reference range has a high and low value between which results are considered normal. Values near the upper or lower limit are mark with (*), Low or High word´s, while anything outside of these limits is considered abnormal. Monocytes and Neutrophils showed values of lower limit and AST/ALT upper limit, respect normal values.

    Table 1 Thyroid Profile

    Table 2 Blood Assay

    Table 3 New Cellular Assay

    Table 4 Serum Electrolytes Level

    Discussion

    THs have various effects on the body, which include electrolyte and water hemostasis. It is also involved in renal development and physiology, because hyponatremia is a serious electrolyte imbalance that can be associated with the involvement of different body systems and a wide range of deleterious changes.9 In the present case, the authors reported a female with the symptoms of severe hyponatremia and serum sodium level of 110 meq/l. This report may justify the appearance of hypothyroidism in the patient, because from a very young age, she had rigorously participated in several marathon races, as well as in 32km races organized in Mexico City. In view of these energetic exercise, she could not explain her new condition, although she had been exposing herself to severe dehydration. However, after being diagnosed with hypothyroidism, the patient was able to plan two pregnancies, and with clinical assistance, she received medical treatment and appropriate nutritional support, and has two completely healthy male children.

    THs have a significant impact on heart function. It upregulates the expression of the sarcoplasmic reticulum calcium-activated ATPase. In a hypothyroid state, TH deficiency results in lower heart rate and weakening of myocardial contraction and relaxation, with prolonged systolic and early diastolic times.10 This could justify the appearance of hypertension in the patient at 40 years of age.

    On the other hand, exposure to COVID-19 may exacerbate clinical disorders in which environmental, vascular factors, inflammation and oxidative damage are implicated in the homeostasis of the patients.11 These disorders induce oxidative damage to metabolically compromised cells that may lead to Metabolic Syndrome (MetS). At worldwide level, the prevalence of MetS is increasing. This situation has led to notorious increase in the demand for natural food and nutraceuticals. Consequently, this promotes the production of these kind of foods, thus, making food-derived antioxidant peptides available for the consumption of both the healthy and patients. The resultant effect of this consumption is reduced production of reactive oxygen species and activation of endogenous antioxidant defense systems in body.12 Food, such as legumes with different bioactive compounds, could reduce the risk of diabetic complications. Demand for leguminous products is growing, because of its low cost and robust contents of several health-promoting components, e.g., saponins.13 Nopal (Opuntia spp.) is very noble plant that contains saponins, which greatly decrease excess glucose. It is by excellence the most utilized cactus in human nutrition.14 In fact, patients receiving antioxidant supplementation have reduced markers of burn stress-induced inflammation, decreased hypermetabolic response, and shorter length of hospital stay.15 Patients with hypothyroidism who developed post-COVID-19 symptoms of vertigo/dizziness and anxiety that receive treatment medicine and appropriate nutritional support may have reduced manifestation of these symptoms and may not have the need to visit the hospital even when their symptoms remain persistent, in addition, the results of thyroid blood tests (Tables 1, 2, 3 and 4) generally each hormone or biomarkers should fall within a reference range that was considered normal.

    Conclusion

    The results of the present clinical case bring into evidence the combined beneficial effects of psychological, clinical and appropriate nutritional support to patients with hypothyroidism and post COVID-19 symptoms. Invariably, this will help to optimize the management of both the rare and common post-COVID-19 clinical manifestations that are the major complaint of people who had suffered this infection.

    Abbreviations

    COVID-19, Coronavirus disease 2019; AST, Aspartate aminotransferase; ALT, Alanine aminotransferase; BMI, Body Mass Index; CV, Cardiac Values; EA, Examination of Abdomen; UE, Upper Extremity; LE, Lower Extremity; DTRs, Deep Tendon Reflexes.

    Acknowledgments

    We thank Dr. Cyril Ndidi Nwoye Nnamezie, an expert translator and native English speaker, a researcher in Medical Science and a physician by profession. The authors express their profound gratitude to the National Institute of Pediatrics (NIP) for the support in the publication of this article issued on the Program A022. The publication of these findings contributes to the benefit of patients who have similar pathologies and are free of institutional permission.

    Author Contributions

    All authors made a significant contribution to the work reported, whether that is in the conception study design, execution, acquisition of data, analysis and interpretation, or in all these areas; took part in drafting, revising or critically reviewing the article; gave final approval of the version to be published; have agreed on the journal to which the article has been submitted; and agree to be accountable for all aspects of the work.

    Consent for Publication

    A written consent was obtained from the participants´ parents because decision-taking was outrightly delegated by the patient to a family member or competent person, who in this case, was the parents. Besides, Ethics Committee of National Institute of Pediatrics approved the publication of case details.

    Disclosure

    The authors report no conflicts of interest in this work.

    References

    1. Almandoz JP, Hossein Gharib. Hypothyroidism: etiology, diagnosis, and management. Med Clin North Am. 2012;96(2):203–221. 10.1016/j.mcna.2012.01.005.

    2. Biondi B, Kahaly GJ, Robertson RP. Thyroid dysfunction and diabetes mellitus: two closely associated disorders. Endocr Rev. 2019;40(3):789–824. doi:10.1210/er.2018-00163

    3. Xin S, Peng H, Chen X, Xijie W, Wang B. Hyperlipidemia and hypothyroidism. Clin Chim Acta. 2022;527:61–70. doi:10.1016/j.cca.2022.01.006

    4. Lauffer P, Zwaveling-Soonawala N, Naafs JC, Boelen A, van Trotsenburg ASP. Diagnosis and management of central congenital hypothyroidism. Front Endocrinol. 2021;12:686317. doi:10.3389/fendo.2021.686317

    5. Rizzo LFL, Mana DL, Serra HA. Drug-induced hypothyroidism. Medicina. 2017;77(5):394–404.

    6. Markou K, Georgopoulos N, Kyriazopoulou V, Vagenakis AG. Iodine-Induced hypothyroidism. Thyroid. 2001;11(5):501–510. doi:10.1089/105072501300176462

    7. Roti E, Uberti ED. Iodine excess and hyperthyroidism. Thyroid. 2001;11(5):493–500. doi:10.1089/105072501300176453

    8. Bridwell RE, Willis GC, Gottlieb M, Koyfman A, Long B. Decompensated hypothyroidism: a review for the emergency clinician. Am J Emerg Med. 2021;39:207–212. doi:10.1016/j.ajem.2020.09.062

    9. Maharjan G, Kumar Yadav M, Khati N, Kumar Yadav S, Ram Shrestha T. Hypothyroidism induced hyponatremia: a case report. J Nepal Med Assoc. 2022;60(253):815–816. doi:10.31729/jnma.7471

    10. Vargas-Uricoechea H, Bonelo-Perdomo A, Sierra-Torres CH. Effects of thyroid hormones on the heart. Clin Investig Arterioscler. 2014;26(6):296–309. doi:10.1016/j.arteri.2014.07.003

    11. Leclère M, Hysenaj A, Meha R, et al. The impact of information about COVID-19 on the endocrine stress system and cognitive distortions. Horm Metab Res. 2023;55(2):89–95. doi:10.1055/a-1997-0550

    12. Yongsheng Z, Fei L, Xin P, Jihong W. Food protein-derived antioxidant peptides: molecular mechanism, stability and bioavailability. Biomolecules. 2022;12(11):1622. doi:10.3390/biom12111622

    13. Calderón Guzmán D, Juárez Olguín H, Veloz Corona Q, Ortiz Herrera M, Osnaya Brizuela N, Barragán Mejía G. Consumption of cooked common beans or saponins could reduce the risk of diabetic complications. Diabetes Metab Syndr Obes. 2020;13:3481–3486. doi:10.2147/DMSO.S270564

    14. Angulo-Bejarano PI, Gómez-García MR, Valverde ME, Paredes-López O. Nopal (Opuntia spp.) and its effects on metabolic syndrome: new insights for the use of a millenary plant. Curr Pharm Des. 2019;25(32):3457–3477. doi:10.2174/1381612825666191010171819

    15. Rehou S, Shahrokhi S, Natanson R, Stanojcic M, Jeschke M. Antioxidant and trace element supplementation reduce the inflammatory response in critically ill burn patients. J Burn Care Res 2018. 39(1):1–9. doi. doi:10.1097/BCR.0000000000000607

    Creative Commons License © 2024 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.